IKT icon

Inhibikase Therapeutics
IKT

Overview Fund Activity

24 hedge funds and large institutions have $6.33M invested in Inhibikase Therapeutics in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 4 closing their positions.

Holders
24
Holders Change
-1
Holders Change %
-4%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
HLA
1
Hamilton Lane Advisors
Pennsylvania
$245K
2
RAM
2
Redmond Asset Management
Virginia
$182K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$785K
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$19K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$124K

Top Sellers

1
SM
1
Sabby Management
Florida
$147K
2
M
2
Murchinson
Ontario, Canada
$0
3
LCM
3
Lynwood Capital Management
Ontario, Canada
$178K
4
RPCONE
4
Retirement Planning Company of New England
Rhode Island
$172K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$279K
Name Holding Trade Value Shares
Change 		Shares
Change %
MAM
26
Mystic Asset Management
Rhode Island
– -$3K -379 Closed
1
2